Page last updated: 2024-11-07

aldosterone and ST Elevation Myocardial Infarction

aldosterone has been researched along with ST Elevation Myocardial Infarction in 2 studies

ST Elevation Myocardial Infarction: A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Monzo, L1
Huttin, O1
Ferreira, JP1
Lamiral, Z1
Bozec, E1
Beaumont, M1
Micard, E1
Baudry, G1
Marie, PY1
Eschalier, R1
Rossignol, P1
Zannad, F1
Girerd, N1
Docherty, KF1
Jhund, PS1

Other Studies

2 other studies available for aldosterone and ST Elevation Myocardial Infarction

ArticleYear
Role of aldosterone in mid- and long-term left ventricular remodelling after acute myocardial infarction: The REMI study.
    European journal of heart failure, 2023, Volume: 25, Issue:10

    Topics: Aldosterone; Heart Failure; Humans; Myocardial Infarction; ST Elevation Myocardial Infarction; Strok

2023
Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early?
    Heart (British Cardiac Society), 2018, Volume: 104, Issue:22

    Topics: Aldosterone; Data Analysis; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; S

2018